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Hydrophilic, partially degradable, and bioactive cements (HDBCs) are starch-containing cements intended to
degrade partially in the human body and, in so doing, allow for bone ingrowth inside the pores formed during
degradation. Therefore, the study of degradation and bioactivity behavior was performed to assess the suitability
of the current HDBCs formulations to achieve those aims. The degradation profile of HDBCs was studied under
different conditions, including incubation in phosphate-buffered saline (PBS) and PBS supplemented with R-amylase
at different concentrations. Thermostable R-amylase was also added to some formulations to allow control of the
degradation rate and its extent. In a second stage the simultaneous phenomena of enzymatic degradation and
bioactivity (both in vitro) was studied. We observed that the degradation of starch present in HDBCs can be
easily controlled by the amount of R-amylase added to the cement and high values of degradation may be achieved
if high enough quantities of enzyme are incorporated. However, the maximum degradation extent is much more
dependent on the total amount of starch present in the formulation than on the amount of enzyme added to it: for
full pore connectivity, the amount of starch should be higher than the percolation threshold for a 3D specimen.
Nonetheless, calcium phosphate was able to nucleate and spread in inner pores of the cement, formed due to
degradation, if they were interconnected. For a more thorough covering of the pores with calcium phosphates the
amount of starch present in HDBCs should be increased to be higher than the percolation threshold.
1. Introduction
Acrylic bone cements were developed for holding a femoral
prosthesis in place and transferring the load received by the
prosthesis to the bone. Although they adequately perform such
function and cemented prosthesis present a survival rate of 82%
after 17 years of implantation,1 in approximately 72% of the
cases1 the reason for failure is the aseptic loosening of the two
interfaces (prosthesis-cement and cement-bone). The bone-
cement interface can be influenced by the toxicity of the
monomer, bone necrosis due to the polymerization heat, inherent
weakness of the cement, and presence of blood and tissue debris
mixed during surgery.2 The most employed method to increase
the strength of the interface is promoting the bone growth on
the surface of the cement. In the past, this property has been
achieved by incorporation of bone particles,3,4 growth hor-
mones,5,6 bioactive glasses7 or glass-ceramics,8,9 and hydroxy-
lapatite (HA).10-12 The last three are the most promising
materials, since they not only impart a bioactive behavior to
the cements but also improve the mechanical properties of the
material, acting as reinforcing fillers.
However, this approach still presents some problems. First,
the contact with bone is totally dependent on the surface
distribution of the bioactive fillers since only the particles at
the surface are available to the bone. If the number of particles
exposed to the bone is low, bone growth will be slow and/or
the interface will not be reinforced. As Shinzato et al.13 showed,
the detaching failure load (between cement and bone) can be
eight times higher for an abraded surface (where the bioactive
particles were intentionally exposed) compared to a normally
cured surface. Second, the affinity between bone and cement
decreased markedly in load-bearing sites due to mechanical
stress or micromotion at the interface: the length of bone in
direct contact with cement decreased almost five times when
the cement was implanted in load-bearing sites.9,14
Therefore, other methods should be developed to create a
stronger, more stable, and longer lasting interface between bone
and cement. One alternative would be to promote the growth
of bone not only in the surface but also in the interior of the
cement. This could be achieved if a partially degradable cement
can be prepared: the gradual degradation of the degradable
component would generate pores and voids that could be filled
by bone, growing due to the bioactive character imparted by
the bioactive fillers. In that sense, the bone cement could be
considered an in situ forming scaffold: immediately after
implantation the cement is a dense construct, but as time
increases it becomes more and more porous, as a typical
biodegradable scaffold.15 One important difference is that while
the latter are designed to be fully biodegradable, these cements
will only degrade partially.
Recently, we developed a novel class of acrylic-based bone
cements: the hydrophilic, partially degradable, and bioactive
cements (HDBCs). They contain a hydrogel-forming monomer
(2-hydroxyethyl methacrylate, HEMA) in the liquid component
of the typical bone cement formulation, partially substituted for
methyl methacrylate (MMA) in order to adjust the mechanical
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and swelling properties of the system. Therefore, the key
characteristics of the hydrophobic, acrylic cements, such as fast
polymerization rate, injectability, and high mechanical proper-
ties, are maintained, and the advantages of hydrogelssgood
compatibility with body fluids and tissues, improved release
behavior of drugs, easier bioactivity,16 and otherssare added.
These hydrophilic bone cements also incorporate a starch-based
blend that can degrade in the body and has already been studied
for a range of biomedical applications such as scaffolds for tissue
engineering,17,18 systems for drug delivery,19 hydrogels,20,21 and
proposed for bone replacement and regeneration applications.22,23
Previous reports have shown that the swelling kinetics of
HDBCs depends on the pH of the surrounding medium,24 the
amount of residual monomer is very low (<1 mol %),25 and
the molar ratio of monomers used determined the swelling
kinetics and extent.26 Our preliminary degradation results did
show that these HDBCs degrade when formulated with R-amyl-
ase, which catalyzes the degradation of starch.27 Addition of
enzymes to control the degradation of materials is beneficial
because enzyme activity can be regulated by environmental
conditions (e.g., pH, temperature, presence of metal ions or other
substances, etc.) and the degradation kinetics can be adjusted
by the amount of encapsulated enzyme into the matrix. Other
starch-based formulations have been prepared containing en-
capsulated R-amylase to develop enzymatically controlled drug
delivery systems.28-31 Goldbart et al.28 developed an enzymati-
cally controlled responsive drug delivery system consisting of
a starch-based tablet incorporating a nonactive R-amylase and
a protein. The enzyme reactivation was made by the presence
of calcium ions, which causes tablet degradation and concomi-
tant release of the protein. Similarly, Dumoulin et al.30
incorporated R-amylase into cross-linked amylose tablets in
order to modulate the release kinetics of drugs with limited
solubility. Incorporated enzyme was more effective than enzyme
present in the solution, even at high amounts.
Our aim, in this work, was to study in greater detail the
degradation phenomena occurring inside these cements and the
possibility, or not, of promoting simultaneous degradation/
bioactivity. It was divided in three stages: (a) study of the
degradation of HDBCs in simulated physiological solutions
containing R-amylase, (b) incorporation of R-amylase in the
cement formulation and study of its effects, and (c) evaluation
of the simultaneous bioactivity/degradation phenomena in a
simulated body fluid (SBF).
2. Materials and Methods
2.1. Preparation of the Formulations and Solutions. Cement
specimens were prepared by adding the solid component to the liquid
component. The solid was constituted of a blend of corn starch/cellulose
acetate 50/50 wt % (SCA) and, in some formulations, by the bioactive
glass Bioglass 45S5 (NovaMin Technology Inc., Florida). The glass
had particle sizes of 4.880 µm and a surface area of 0.0571 m2/g. The
polymer particles were smaller than 125 µm. The liquid was constituted
of 2-hydroxyethyl methacrylate (HEMA), which was used as received.
In one formulation the liquid was a mixture of HEMA and methyl
methacrylate (MMA) at a molar ratio of 1/2 (HEMA/MMA). Benzoyl
peroxide powder (BPO) was used as the polymerization initiator at a
molar concentration of 0.0072 with respect to the monomer amount
(that is, 0.72 wt % of the solid). Dimethyl-p-toluidine (DMT) was used
as the activator of the initiator at a molar concentration of 0.67 with
respect to the BPO amount (that is, 0.57 vol % of the liquid). The
solid/liquid ratio employed was 65/35, and the concentration of the
glass, when used, was fixed at 32.5 wt % of the total mass (that is, 50
wt % of the solid component). Water (or thermostable enzyme, please
see details below) was added as an extra component, and its mass was
not considered for calculation of the solid/liquid ratio. The composition
of the various formulations is shown in Table 1.
Preparation of specimens for subsequent tests was carried out
following the traditional method. The activator DMT was dissolved in
the liquid phase. Initiator of free radical polymerization reaction was
added to the solid phase. Both phases were mixed and stirred by hand
until the mixture became paste-like with a high viscosity; the mass
was then placed into a poly(tetrafluoroethylene) (PTFE) mold to allow
it to cure. Two molds were employed, one for cylindrical specimens
(12 mm height, 6 mm diameter) and another for bar-shaped specimens
(50 × 5 × 1.5 mm3). The same starch polymeric blend (SCA) was
processed by conventional injection molding under optimized conditions
in a Klockner-Ferromatik Desma FM20 machine to produce compact
disks (Ø ) 1 cm, e ) 1.5 mm).
Two different enzyme preparations were used in this study: one is
a conventional bacterial R-amylase from Bacillus amyloliquefaciens
(Optisize 160), and the other is a thermostable R-amylase from a
genetically modified strain of Bacillus licheniformis (SPEZYME FRED,
20700 LU/mL). Both were kindly supplied by Genencor International
B. V. (Leiden, The Netherlands) and provided in the liquid form. The
first enzyme was used for preparation of the degradation solutions at
physiological conditions, and the latter was used both in the degradation
studies and also in the studies of its incorporation in the cement
formulations. The various enzyme solutions were then prepared by
diluting the enzyme preparations in buffer.
To perform the degradation and bioactivity tests of the developed
formulations, four solutions were prepared: (a) phosphate-buffered
saline (PBS) solution (0.01 M, pH 7.4), (b) PBS supplemented with
150 U/L1 (one enzyme unit (U) is defined as the amount of enzyme
able to catalyze the hydrolysis of R-1,4-glycosidic linkages of a soluble
potato starch (1%, w/v) in PBS solution (pH 7.4) at 37 °C with the
release of 1 µmol of reducing sugar, measured as glucose, per minute)
of conventional R-amylase (PBSa), (c) PBS supplemented with 28.7
LU/mL of thermostable R-amylase (PBSta), and (d) simulated body
fluid (SBF) solution containing 142.0 mM Na+, 5.0 mM K+, 2.5 mM
Ca2+, 1.5 mMMg2+, 147.8 mM Cl-, 4.2 mM HCO3-, 1.0 mM HPO42+,
and 0.5 mM SO42- in distilled water and buffered with 50 mM of tris-
(hydroxymethyl)amino methane (TRIS). The SBF solution has ion
concentrations approximately equal to those of human blood plasma.
It has been widely used for the in vitro assessment of the bioactivity
of artificial materials by examining their apatite-forming ability in the
fluid.
2.2. Degradation Tests. The water uptake and degradation behavior
of the prepared bone cement formulations was studied over a period
of 12 weeks. Cylindrical specimens were immersed in PBS, PBSa, or
PBSta at a ratio of 1:15 (specimen mass:solution volume) and incubated
Table 1: Description of the Cement Formulations Prepared in
This Study
code description use
C00 base formulation, control all tests
CM0 C00 containing MMA in
the liquid component.
C10 C00 + 0.10 mL water degradation tests
S05 C00 + 875 LUtaa/gsta degradation tests
S10 C00 + 1750 LUtaa/gst degradation tests
S50 C00 + 8750 LUtaa/gst degradation tests
SM5 CM0 + 875 LUtaa/gst degradation tests
BC0 C00 containing 32.5 wt %
of bioactive glass
degradation/bioactivity tests
S15 C00 + 1592 LUtaa/gst degradation/bioactivity tests
B15 BC0 + 1592 LUtaa/gst degradation/bioactivity tests
B30 BC0 + 3185 LUtaa/gst degradation/bioactivity tests
a LUtaa/gst ) liquefon units of thermostable R-amylase by mass (g) of
starch in the formulation. One LU is the measure of digestion time required
to produce a color change with iodine solution.
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at 37 °C under static conditions. The specimens were removed at regular
intervals, being taken out of the solution, rinsed with distilled water,
blotted on filter paper to remove surface solution/water, and immediately
weighed. They were then dried at controlled conditions (23 °C, 55%
RH) to constant weight in order to determine the percentages of water
uptake and weight loss. The degradation solution was frozen for later
analysis (determination of reducing sugars in solution).
Compact injection-molded disks of SCA controls were also incubated
in PBS and PBSa at a ratio of specimen mass:solution volume equal
to 1:10 at 37 °C for 12 weeks. At the end of the incubation period the
disk specimens and solutions were treated as described for the cement
formulations and the results compared with the ones obtained for the
cements in the same incubation conditions.
Water uptake (WU) was calculated using the following equation
where mt is the wet mass of the specimen at time t (days) and mf is the
final mass after immersion and drying. The percentage of weight loss
(WL) was calculated as follows
where m0 is the initial mass prior to immersion (t ) 0).
R-Amylase is an endo-specific enzyme which catalyzes the hydroly-
sis of R-1,4-glycosidic linkages of starch to maltose and dextrins,
reducing the molecular size of starch. The activity of R-amylase can
be monitored by measuring the concentration of reducing sugars
released into the solution. The concentration of reducing sugars of all
degradation solutions was determined using the dinitrosalicylic acid
(DNS) method.32 The DNS procedure is based on the reduction of the
3,5-dinitrosalicylic acid to 3-amino-5-nitrosalicylic acid under alkaline
conditions, being the carbonyl group of sugars oxidized producing
carboxylic groups. During this reaction there is the development of a
colored complex whose intensity can be measured at 540 nm.
Quantification of reducing sugars in the degradation solutions was
performed in a SpectraMax 340PC microplate spectrophotometer
(Molecular Devices Corp., Sunnyvale) and using a calibration curve
of standard glucose concentrations.
The morphology of the specimens after degradation was analyzed
with a Leica Cambridge S360 (Leica Cambridge Ltd., Cambridge, U.K.)
scanning electron microscope (SEM). Before observation, specimens
were dried at room temperature for several days and gold-coated by
ion sputtering (Sputter Coater SC502, Fisons Instruments, U.K.).
Figure 1. Degradation profile of C00 at 37 °C in PBS solution (pH
7.4) with or without R-amylase (150 U/L) in terms of weight loss (a)
and concentration of reducing sugars in solution (b). No significant
differences between the two samples were found for any time period.
WUt ) (mt - mfmf ) × 100 (1)
WLt ) (mf - m0m0 ) × 100 (2)
Figure 2. Comparison of the degradation rate, measured as weigh
loss (a) and reducing sugars in solution (b), of SCA cements (C00)
and disks after 12 weeks of incubation in PBS solution (pH 7.4)
without or with R-amylase (150 U/L) at 37 °C. Significant differences
(p < 0.05) were found only for the pair marked with an asterisk (*).
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2.3. Degradation/Bioactivity Tests. For these tests bar-shaped
specimens were used over a period of 16 weeks of immersion in SBF
solution at 37 °C. A fixed volume of 10 mL of SBF was used for all
specimens. They were removed at regular intervals, being taken out of
the solution, rinsed with distilled water, and sectioned to expose their
cross-sectional area. Then the specimens were frozen at -80 °C and
freeze-dried at a condenser temperature of -80 °C and a pressure of
approximately 0.030 mBar for 72 h in a Cryodos freeze-drier (Telstar
Industrial, S. L., Terrassa, Spain). During the freeze-drying process no
cryoprotectants were used taking into account the polymeric nature of
the samples. No freezing damage, due to ice formation, is expected in
this type of sample. After freeze-drying the samples were gold-coated
and observed by SEM. Due to the growth of an apatite layer, WU and
WL were not determined in these experiments. The concentration of
reducing sugars in solution was determined as described before, and
the final values were normalized considering a hypothetical mass of
0.1 g of starch per specimen.
The formation and growth of an apatite layer on the specimen surface
was visualized by scanning electron microscopy and confirmed by
energy dispersive spectroscopy (EDS), which allows the qualitative
determination of the atoms present in the layer. Specimens for EDS
analysis were not sputtered, while the others were gold-coated as before.
2.4. Statistical Analysis. The normality of the data was checked by
visual inspection of normal probability plots for each sample studied
and also by applying the Shapiro-Wilk’s W test.33 For all pairs of
samples with normal distribution, Student’s t tests for independent
samples were performed to test differences among them. In a few cases
the samples did not follow a normal distribution; in those cases a
Mann-Whitney U test (nonparametric test) was performed. In all tests
the level of significance was fixed at p < 0.05. Therefore, throughout
the following discussion the values were considered different if their
difference was significant at this level. Statistical analysis was performed
with Statistica 5.0 (StatSoft).
3. Results and Discussion
3.1. Degradation of HDBCs in Simulated Physiological
Solutions Containing R-Amylase. As Figure 1 shows there was
no indication of an increased degradation of the starch contained
in the bone cement when the specimens were immersed in a
solution containing R-amylase in concentration similar to those
found in the human blood plasma. In this study we used a
concentration of 150 U/L of R-amylase, while it has been
reported that the reference concentrations of this enzyme in
serum is in the range of 46-244 U/L.34 This enzyme catalyzes
the hydrolytic degradation of starch, releasing low molecular
weight sugars (glucose, maltose, and other soluble oligosac-
charides) to the solution as a result of the random chain scission.
Figure 3. Degradation profile of different formulations of HDBCs in
PBS in terms of weight loss (a) and concentration of reducing sugars
in solution (b).
Figure 4. Degradation profile of different formulations of HDBCs in
PBS or PBSta in terms of weight loss (a) and concentration of
reducing sugars in solution (b).
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If some starch degradation was occurring, we would expect to
observe higher weight loss as well as a higher concentration of
reducing sugars in the solution containing R-amylase. However,
none of them occurred: none of the observed differences were
significant at a 0.05 confidence level. The WL observed for
both samples may be attributed to the leaching of low molecular
weight molecules and plasticizers, which exist in the biodegrad-
able blend,35 and nonpolymerized monomers or oligomers,
which are soluble in water and may be released after water
uptake.26
To identify the possible reasons for this behavior, we
performed similar degradation tests with injection-molded disks
of pure SCA, whose results are shown in Figure 2. Although
the WL was similar in samples immersed in both solutions, the
concentration of reducing sugars was 2.3 times higher for the
sample in contact with R-amylase, demonstrating that in this
case the R-amylase is playing an important role in the degrada-
tion process.
The obtained results indicate that the lack of degradation of
the starch present in the HDBCs may be due to the inacces-
sibility of the enzyme to the starch molecules. In the tested
samples the starch amount available is approximately 32.5 wt
%, while in the SCA disks it is ∼50 wt %. Due to the proximity
of the densities of all pure components (1.27 for poly-HEMA,
1.3 for cellulose acetate, and 1.4 for starch) we can hypothesize
that the volume fraction resembles the weight fraction. Enzymes
are proteins composed of sequences of amino acids folded into
a three-dimensional structure with different levels of organiza-
tion. The dimension of macromolecules (e.g., proteins with MW
between 10 and 1000 kDa) is in the range of 2-10 nm.36 The
molecular weight of R-amylase from Bacillus amyloliquefaciens
(enzyme used in this study) has been reported to be 55-58 kDa37.
In fact, the size of the enzyme is too large to allow its diffusion
through the polymeric matrix; therefore, only the starch at or
close to the surface would be available for enzymatic attack. In
order for the inner starch particles to be accessible, the
percentage of starch in the material should be higher than the
percolation threshold (pc), that is, the minimum concentration
of the dispersed medium that creates full connectivity from the
bottom to the top surface.38 In such case, degradation of the
starch would create a connected network of pores and voids
that would allow transport of the enzyme to the interior of the
material; the successive steps of starch degradation-enzyme
migration would cause degradation of the total starch in the
sample. Percolation threshold depends on the geometry of the
medium; for a cubic lattice, pc ) 31.17%.38,39 Moreover, the
accessibility of the dispersed phase depends also on the homo-
geneity of the dispersion and the size of the particles: if there
is aggregation or a large distribution of particle sizes, the access-
ibility will not follow that indicated by percolation theory.39
Nonetheless, as an example of the importance of the amount of
degradable component, Wool et al.38 found that by increasing
the starch concentration from 20 to 35 vol % in a polyethylene
matrix the aerobic biodegradation of starch increased from 7 to
75 wt % after 20 days. Therefore, one can conclude that the
volume fraction of starch in HDBCs is insufficient to create
percolation and, as a consequence, a very low amount of the
starch will be degraded, as in fact happened. If a higher amount
was used, the degradation extent would have been higher, as
the results indicate for pure SCA (degradation tests with disks).
Despite the different geometries of cements and disk specimens
impede a direct and quantitative comparison between them,
Figure 2b seems to confirm this assumption since the amount
of RS released to the solution was considerably higher for the
SCA disks than for the SCA-based cements. Therefore, to allow
degradation of all the starch present in HDBCs, these should
either incorporate a thermostable enzyme in their formulation
or contain a higher amount of starch, well above the pc. In the
following section we report the results of the former approach,
while the latter will be presented in a future paper.
3.2. Effect of r-Amylase Incorporation on the Degradation
Behavior of the Cement Formulations. The incorporation of
Figure 5. SEM micrographs of the cross-section of various specimens after immersion in PBS: (a) C00, 2 weeks; (b) C00, 8 weeks; (c and d)
SM5, 2 weeks.
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different amounts of R-amylase was performed in order to
control the degradation rate of starch in the formulations. As
Figure 3 shows, the presence of enzyme has a strong influence
on the degradation of the samples; even after 1 week the
concentration of reducing sugars for sample S50 was 58 times
higher than that for the control (C00). Although the trend
(regarding the influence of increasing amounts of R-amylase)
is the same for both weight loss and reducing sugars results,
the effect of adding the enzyme is much stronger for the amount
of reducing sugars than for WL: RS is related to the number
of molecules released to the solution, while WL is related to
their total mass. Therefore, one would expect a stronger
influence of the enzyme on the results of RS since R-amylase
catalyzes the random degradation of starch molecules to glucose
or other soluble maltooligosaccharides. However, at early stages
of degradation, only small molecular weight fragments are
released and therefore no significant changes in the total mass
of the material/specimen were observed. On the other hand, the
soluble low molecular weight sugars released into the solution
are more accessible for further enzyme hydrolysis (when
compared with the high molecular weight of starch molecule),
which also contribute to the increase of reducing sugars in
solution. Regarding WL, it is clear that there is some influence
of the addition of an extra amount of liquids: in fact, the
difference between C10 and C00 is approximately constant and
close to the amount of water added to C10 (∼2.4 wt %).
Therefore, one could hypothesize that the maximum contribution
to the WL of the water present in the enzymatic solution would
be around this value since, for example, 0.10 mL of the solution
was added to sample S10. In terms of RS, as expected, the water
had no effect; the degradation of starch can therefore be
attributed solely to the presence of R-amylase.
Comparing S10 formulation with C10, we observed that after
12 weeks only about 10% of the WL may be attributable to
starch degradation (that is, WLS10 - WLC10) due to the hydro-
lytic effect of the enzyme. This is much lower than the quantity
of starch in the formulation (∼32.5 wt %) and may demonstrate,
once again, that the lack of full connectivity among starch sites
avoids complete degradation of this material. To clarify this
point and avoid any misunderstanding related to the different
R-amylases used in parts A and B of this study (conventional
R-amylase in part A and thermostable one in B), we performed
a final test comparing S05, C00, and C00 immersed in PBS
Figure 6. SEM micrographs of the surface of specimens after immersion in SBF: (a) BC0, 4 weeks; (b) B30, 1 week; (c) BS5, 2 weeks; (d)
BS5, 12 weeks.
Figure 7. EDS spectra of the surface of BC0 (a) and B15 (b) after
2 weeks in SBF.
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containing exactly the same amount of enzyme as that added
to S05 (that is, 28.7 LU/mL). The results are presented in Figure
4 and definitively demonstrate the lack of availability of starch
to the R-amylase present in solution. For the current systems
the enzyme must be added to the formulation to promote starch
degradation. This is a very important conclusion.
Besides varying the amount of added enzyme, another way
of controlling the degradation of starch can be achieved by
changing the hydrophilicity of the formulation. This is also
displayed in Figure 3. The RS for SM5, after 4 weeks, was
always significantly lower than that for the more hydrophilic
counterpart (S05). SM5 is more hydrophobic due to addition
of a hydrophobic monomer (MMA), which amounts to 66.7
mol % of the monomer mixture. On the other hand, WL was
higher, which was not surprising since we have already shown26
that this may happen for such systems; the probable causes are
a different conformation of acrylic chains and a higher amount
of unpolymerized monomer due to the different composition
of the monomer mixtures.
As a result of the enzymatic degradation, one should expect
the appearance of pores and voids in the volume previously
occupied by the starch (Figure 5). After 8 weeks C00 remained
basically a dense specimen with few shallow and isolated (not
connected) pores. For the specimens containing R-amylase, a
completely different scenario was observed: the SEM micro-
graphs of their cross sections showed a homogeneously dis-
tributed porosity, which presented a certain degree of connec-
tivity. The pore size was not very high (since they were limited
by the particle size of SCA, that is 125 µm) and had a round
shape, confirming that, in general, they were formed by
degradation of a particulate filler (the starch present in SCA)
while the structure was kept by the inert acrylic matrix. The
low level of degradation is confirmed; it is clear in the
micrographs that the pores represent a low amount of the total
area, the majority of which is occupied by the matrix and
undegraded starch. Even with longer degradation periods the
total pore volume was not sufficient for achieving full con-
nectivity. Clearly, a higher amount of starch is needed to that
aim being achieved.
3.3. Evaluation of the Simultaneous Bioactivity/Degrada-
tion Phenomena in a Simulated Body Fluid (SBF). The main
purpose of the biodegradable component of the bone cement is
to allow space for bone growth inside the cement and not only
on the surface as occurs with all other bioactive cement
formulations. Therefore, we wanted to know if the presence
and activity of the enzyme disturbs apatite formation and growth
(and vice versa, that is, if the apatite growth alters the
degradation rate) and if the apatite is able to grow inside the
pores formed during degradation.
Figure 6 compares the apatite nucleated on the surface of
specimens with and without enzyme. Both the morphology and
size of the apatite crystals which constitute the layer are very
similar, almost identical. Moreover, as Figure 6c shows, the
layer was dispersed along the entire surface and for longer
immersion times (Figure 6d) the area occupied by the layer and
its thickness increased. In terms of the composition of the layer,
at least qualitatively, they are also identical, as shown in Figure
7. Both layers are composed only of Ca and P, with residual
amounts of Si (present in the glass under the layer) and Cl
(precipitated from the solution).
On the other hand, the presence of the glass and the apatite
layer seemed to change the degradation rate of the cements
(Figure 8). Using a similar system (which contained a different
bioactive glass) we have already shown7 that the WL (in normal
saline solutions) of cements containing glass, after 1 week, can
be up to 2.5 times higher than the WL for systems without glass.
This would create a higher volume of voids (especially on the
glass-polymer interface), allowing for easier diffusion of the
enzyme to the starch sites; the degradation rate of starch would
therefore be higher for B15 in the first week of immersion.
However, at later stages (up to 8 weeks) the trend was inverted;
this was not surprising (given the discussion outlined in the
previous section) since the total amount of starch in B15 was
one-half that in S15. Starch was present in a concentration even
further from the percolation threshold; therefore, the amount to
be degraded was lower than in S15. Indeed, after 2 weeks there
seemed to be stagnation in the degradation with the levels of
RS reaching a plateau. Finally, for long degradation times (more
than 8 weeks) there were no significant differences between
both samples, although the averages were always higher for S15.
The longer the degradation period, the more inhomogeneous
the degradation profile (noticeable as a strong increase in the
standard deviation) with large variations in the amount of
specimens in the same period. In our opinion, this was a result
of the inaccessibility of all the starch to the enzyme; therefore,
in different specimens the distribution of starch and enzyme in
Figure 8. Degradation profile (in terms of concentration of reducing sugars in solution) of different HDBC formulations in SBF. Significant
differences (p < 0.05) were as follows: between B15 and S15 at 1 and 8 weeks; between BC0 and S15 at all time periods; between BC0 and
B15 at all time periods.
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the space was different, and slight differences could make more
(or less) starch available to the enzyme, markedly changing the
amount degraded.
The above discussion is corroborated by the SEM micro-
graphs (Figure 9). Even after 16 weeks of immersion the
porosity in B15 was low and with no connectivity (Figure 9a).
One may assume that the R-amylase had access only to the
starch in its immediate vicinity and/or to the starch surrounding
glass particles, where the weak interface provided a higher
surface area. Although specific techniques (microcomputed
tomography, mercury intrusion porosimetry) were not employed
to determine the connectivity, Figure 9b shows in more detail
the closeness and apparent lack of connectivity of the pores. A
completely different picture was observed for S15 (Figure 9b),
with a much higher number of pores, with those well connected
among them. However, as outlined above, there was a large
Figure 9. SEM micrographs showing the formation of porosity in (a) B15 after 16 weeks of immersion, (b) B30 after 8 weeks of immersion, (c
and d) S15 after 8 weeks of immersion. All specimens immersed in SBF at 37 °C.
Figure 10. Formation of calcium phosphate on surface pore walls of B15 after 1 (a) and 16 (b) weeks of immersion. Spreading of calcium
phosphate nuclei to inner pores near the surface in B30 after 2 weeks of immersion (c) or to pores near glass particles (d). All specimens
immersed in SBF at 37 °C.
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heterogeneity among specimens (or among different regions of
a same specimen); Figure 9d shows a different pattern of
porosity. As we were working very close to the percolation
threshold of a 3D structure, small inhomogeneities of the local
distribution of both the starch and the R-amylase could have a
strong effect on the degradation profile and on the porosity
distribution.
Given the low level of starch degradation in B15 and,
consequently, the lack of pore connectivity, our aim of observing
apatite growth inside inner pores was not achieved. Obviously,
pores must be interconnected for spreading of the apatite layer
to the interior of the material. However, we observed some
interesting findings. Figure 10a and b shows that at early stages
of apatite formation (1 week) nuclei were already being formed
on the walls of surface pores. After 16 weeks a dense layer had
been formed without covering the pores; instead, the apatite
layer was also found on the pores. In an attempt to generate
more pores at the early stages of degradation, we used a
formulation with an increased amount of enzyme (B30) and
observed that apatite nuclei did form on the walls of inner pores
near the surface (Figure 10c), meaning that it is indeed possible,
if adequate pore connectivity is achieved, to nucleate apatite
inside the cements. Moreover, as seen in the right-hand side of
Figure 10c and in Figure 10d, even if the pores were closed,
not connected, few apatite nuclei were observed on the walls
of those near glass particles (as well as on the surface of the
glass particles themselves). It seems that the high values of WU
of these systems, the pores formed during degradation, and the
voids around glass particles formed due to water attack to the
interface7 were contributing to the creation of a microenviron-
ment inside the material that was simulating the one existing at
the external surface, being propitious to the nucleation of an
apatite layer. This is a promising indication that bone ingrowth
inside the material, when implanted, might be possible.
4. Conclusions
In this work we have shown that HDBCs are materials
susceptible to enzymatic degradation, catalyzed by R-amylase.
The rate of degradation can be easily tailored by means of proper
choice of the hydrophilicity of the formulation or the amount
of thermostable R-amylase added to the composition. The total
amount of starch in the formulation proved to be a more
important factor than the quantity of enzyme since a minimum
concentration of starch is required to provide full connectivity
among the pores. With our current formulation the amount of
starch was below this percolation threshold; therefore, full
connectivity could not be achieved. Starch amounts can, of
course, still be increased further in future studies, and in such
case, even the R-amylase present in the human blood plasma
might be enough to provoke starch degradation, as it occurred
with injection-molded SCA disks, which contain more starch
than HDBCs.
This system was also able to promote the nucleation and
growth of an apatite layer on the surface and, at a lower extent,
on the walls of superficial and inner pores. This is an important
prerequisite for successful application of bone cements since it
indicates that, in vivo and with a higher degree of connectivity,
bone will be able to grow inside the pores formed during
degradation. This will surely increase the interfacial strength
cement-bone and make the cement more stable, solving one
of the most important causes of failure in hip replacements.
For better performance of the HDBCs, an alternative method
to promote bioactivity should be employed since the glass
reduced the propensity of the starch to be degraded and, as
consequence, the possibility of forming a connected network
of pores.
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